RxDoctor Payments Data

Javid Ghandehari

Pain Medicine · Santa Monica, CANPI 1306002761

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $187,266 of the $188,273 with a category attached, or 99.5%. Pfizer accounts for 99.5% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2024 at $143,234 and has fallen 69.3% since, to $44,032 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$188,273in general payments, 2019–2025

Across 8 payments — averaging $23,534 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$187K
  • Vertex$1K
$2,514,697in research payments, 2019–2025

Across 8 payments — averaging $314,337 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amphastar Pharmaceuticals, Inc.$1.3M
  • E.r. Squibb & Sons, L.L.C.$1.1M
  • Beigene Switzerland GmbH$72K

What the payments were for

  • Consulting fees$187,26699%
  • Travel & lodging$9821%
  • Food & beverage$250%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer2$187,266
Vertex6$1,007

How this compares

$188,273 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Other pain medicine in Santa Monica

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →